Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Alivus Life Sciences Ltd.	Balance Sheet

NSE: ALIVUSEQ BSE: 543322ISIN: INE03Q201024INDUSTRY: Pharmaceuticals

BSE

Rs 1035.10

Open: 1060.00

Today's Range 1034.10

1077.40

NSE
Rs 1044.60
-19.50 ( -1.87 %)

-27.55 ( -2.66 %)

Prev Close: 1062.65

52 Week Range 830.00

1224.00

You can view the Balance Sheet for the last 5 years.

Market Cap. (Rs.)	12821.04 Cr.	P/BV	4.05	Book Value (Rs.)	257.92
52 Week High/Low (Rs.)	1225/819	FV/ML	2/1	P/E(X)	22.71
Bookclosure	01/09/2025	EPS (Rs.)	45.99	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1227.35	1225.37	1225.27	1225.27	1225.27

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	24.55	24.51	24.51	24.51	24.51
Total Share Capital	24.55	24.51	24.51	24.51	24.51

Reserves and Surplus	3307.59	2792.87	2307.82	2107.02	2026.31
Total Reserves and Surplus	3307.59	2792.87	2307.82	2107.02	2026.31
Employees Stock Options	0.00	0.00	0.00	6.68	3.50
Total Shareholders Funds	3332.13	2817.37	2332.32	2138.21	2054.31

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	57.79	54.43	48.79	42.43	31.50
Other Long Term Liabilities	48.79	50.96	14.76	17.09	1.20
Long Term Provisions	36.15	18.54	15.77	0.00	0.00
Total Non-Current Liabilities	142.73	123.92	79.32	59.53	32.70

CURRENT LIABILITIES
Trade Payables	372.37	390.46	368.66	396.56	307.72
Other Current Liabilities	105.76	62.74	58.08	92.32	61.84
Short Term Provisions	29.91	16.96	12.03	15.54	14.44
Total Current Liabilities	508.04	470.16	438.77	504.41	384.00

Total Capital And Liabilities	3982.90	3411.45	2850.41	2702.15	2471.01

ASSETS
NON-CURRENT ASSETS
Tangible Assets	1028.32	942.67	795.01	774.89	584.65
Intangible Assets	19.58	12.28	10.05	5.74	10.38
Capital Work-In-Progress	273.40	94.25	101.19	49.35	91.69
Intangible Assets Under Development	0.00	7.66	4.80	12.26	0.00
Fixed Assets	1321.30	1056.86	911.05	842.25	686.72
Non-Current Investments	0.08	0.08	0.08	0.08	0.08
Other Non-Current Assets	12.16	19.36	23.29	9.49	19.63
Total Non-Current Assets	1333.54	1076.30	934.41	851.81	706.42


CURRENT ASSETS
Current Investments	780.38	477.62	0.00	0.00	0.00
Inventories	691.93	673.95	666.59	604.17	516.24
Trade Receivables	1072.96	969.74	765.43	806.77	673.49
Cash And Cash Equivalents	2.13	71.24	301.59	309.40	512.16
OtherCurrentAssets	101.95	142.62	182.38	130.01	62.69
Total Current Assets	2649.36	2335.16	1916.00	1850.34	1764.58

Total Assets	3982.90	3411.45	2850.41	2702.15	2471.01

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	37.92	34.20	12.83	50.42

BONUS DETAILS
Bonus Equity Share Capital	0.00	19.60	19.60	19.60	19.60

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	0.08	0.08	0.08	0.08

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00	477.62	0.00	0.00	0.00

Market

Derivatives

Mutual Fund

IPO

Quick Links

Alivus Life Sciences Ltd.

Balance Sheet